All In MedTech

Device Trial Radar · NCT01917591

Healing of Punch Graft Wounds. Comparative Study Between MariGen and Oasis: a Non-inferiority Study

Healing of Punch Graft Wounds With Two Biologic Exracellular Matrices; a Non-inferiority Study

Last checked: Nov 19, 2026Latest source record: Mar 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

81

Actual

Start

Jan 2013

Primary completion

Jun 2013

Study completion Jul 2013

Sponsor

Lead sponsor
Kerecis Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Aug 6, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective is to determine, if healing of punch biopsy wounds treated with the fish skin derived MariGen Wound dressing is non-inferior to healing with wounds treated with pig intestines derived Oasis Sheet wound dressing. Secondary endpoints are: Incidence of erythema, Pain, Infection, Quantitative measurements of autoantibodies at baseline and 4 weeks after start of treatment

Conditions

  • Punch Biopsy Wounds
  • Healing Times

Interventions

  • Punch biopsies treated with MariGen Wound ECM dressingDevice

    Weekly dressing changes and review of wounds.

  • Punch biopsies treated with Oasis ECM dressingDevice

    Weekly dressing changes and wound review

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. wound healingTime frame: 28 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Læknastofur Skipholti

    Reykjavik, Iceland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.